Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen bonded directly to ring carbon of the purine ring...
Patent
1995-12-22
1999-07-13
Berch, Mark L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen bonded directly to ring carbon of the purine ring...
544271, A61K 3152, C07D47304, C07D47308
Patent
active
059228687
ABSTRACT:
Use of xanthine derivatives for the treatment of nerve damage following an interruption in blood circulation.
The invention relates to the use of xanthine derivatives of the formula I ##STR1## in which R.sup.2 is a (C.sub.1 -C.sub.4)-alkyl group and at least one of the symbols R.sup.1 and R.sup.3 is a radical of the formula II or III ##STR2## in which A is CHOH, CO or dioxolane, R.sup.4 is a hydrogen atom or a (C.sub.1 -C.sub.4)-alkyl group and n is 0 to 5, and in which R.sup.5 and R.sup.6 are hydrogen atoms or (C.sub.1 -C.sub.4)-alkyl groups or, together with the nitrogen atom to which they are bonded, form a 5- to 7-membered ring, it being possible for one carbon atom to be replaced by an oxygen or nitrogen atom, m is 1 or 2 and the other radical R.sup.1 or R.sup.3, if appropriate, is a hydrogen atom, a (C.sub.1 -C.sub.6)-alkyl group or a (C.sub.3 -C.sub.6)-alkenyl group, for the preparation of medicaments for the prophylaxis and treatment of nerve damage following an interruption in blood circulation, and novel xanthine derivatives, and to processes for their preparation.
REFERENCES:
patent: 3737433 (1973-06-01), Mohler
patent: 4242345 (1980-12-01), Brenner
patent: 4289776 (1981-09-01), Mohler
patent: 4372959 (1983-02-01), Goring
patent: 4833146 (1989-05-01), Gebert
patent: 4845102 (1989-07-01), Sakuri
patent: 5082845 (1992-01-01), Wolf
patent: 5109003 (1992-04-01), Tanaka
patent: 5310666 (1994-05-01), Aretz
Miyamoto, J Med Chem 36(10) 1380 (May 14, 1993).
Klosa, Chem Abs 51, 1195e,f (1956.
Ruffini, Chem Abs 51, 8975 f (1955.
Brierly in "Greenfields Neuropathology," 4.sup.th Ed, pp. 125-156 (1984).
Goodman, Ed, "Pharmacological Basts of Therapeutics," 5.sup.th Ed (1975) pp. 882-893.
Hayashi, Chem Pharm Bull 16(3), 426(1968).
Romieh, Egypt. J. Pharm. Sci 34, 455(1993).
Furrer Harald
Gebert Ulrich
Grome John J.
Rossmanith Erhard
Schneider Ernst-Jurgen
Berch Mark L.
Hoechst Aktiengesellschaft
LandOfFree
Use of xanthine derivatives for the treatment of nerve damage fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of xanthine derivatives for the treatment of nerve damage fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xanthine derivatives for the treatment of nerve damage fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276612